Cohen S N
Fed Proc. 1977 Sep;36(10):2356-8.
The National Commission is about to finalize its recommendations with regard to research in children. It is significant that the commission will propose that research in children is necessary and should be supported. Clinical pharmacologic studies in infants and children require encouragement, as well as support, if drugs are to be developed in the future that do not have limited indications for the pediatric-aged patient, due to incomplete pediatric studies. The ethics of conducting pharmacologic investigations in infants and children have been discussed and recommendations have been prepared by the Committee on Drugs of the American Academy of Pediatrics. These discussions and recommendations differ in some significant ways from the most recent draft available from the National Commission.
国家委员会即将敲定其关于儿童研究的建议。重要的是，该委员会将提议儿童研究是必要的且应得到支持。如果未来要开发出对儿科患者没有有限适应症的药物，由于儿科研究不完整，那么婴幼儿和儿童的临床药理学研究就需要鼓励和支持。美国儿科学会药物委员会已经讨论了在婴幼儿和儿童中进行药理学研究的伦理问题，并制定了相关建议。这些讨论和建议在一些重要方面与国家委员会的最新草案有所不同。
